Glioblastoma multiforme Clinical Trials

A listing of Glioblastoma multiforme medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 349 clinical trials
Featured trial
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209) (FIGHT-209)

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblatoma (GBM) or other primary CNS tumors with an activating FGFR1-3 mutation or fusion/rearrangement

measurable disease
oligodendroglioma
ccnu
recurrent tumor
temozolomide
  • 3 views
  • 17 Sep, 2022
  • 21 locations
Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM

glioblastoma (rGBM) undergoing carboplatin monotherapy.

glioblastoma multiforme
tumor progression
  • 14 views
  • 15 Dec, 2021
  • 4 locations
GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

The purpose of this study is to evaluate the efficacy and safety of GX-I7 in combination with bevacizumab in subjects with recurrent glioblastoma.

  • 0 views
  • 27 Jul, 2022
  • 1 location
The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

The study is to evaluate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy for patients with maligant glioblastoma multiforme. Autologous TiLs should be given by intravenous

  • 0 views
  • 30 Apr, 2022
  • 1 location
Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients With Recurrent Glioblastoma (GBM)

This study is intend to explore the efficacy and safety of combined treatment of camrelizumab and bevacizumab in adult patients with recurrent glioblastoma.

  • 0 views
  • 17 Jul, 2021
  • 1 location
B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

of adult subjects with recurrent IDH wild-type GBM using a standard 3+3 dose escalation design.

  • 0 views
  • 08 Aug, 2022
  • 1 location
Functional and Ultrasound Guided Resection of Glioblastoma (FUTURE-GB)

Functional and ultrasound-guided resection of glioblastoma: assessing the use of additional imaging during surgery to improve outcomes for patients with glioblastoma brain tumours

  • 0 views
  • 18 Jun, 2022
  • 17 locations
Feasibility of Individualized Therapy for Recurrent GBM

glioblastoma in a timely fashion. Collected tumor tissue and blood will be examined using a new diagnostic testing called University of California, San Francisco (UCSF) 500 Cancer Gene Panel which is done at

neutrophil count
gliosarcoma
glioblastoma multiforme
cancer
  • 13 views
  • 01 Feb, 2022
  • 1 location
Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

A study to determine the feasibility and safety of individualized cancer stem cell targeted therapy based on high-throughput functional profiling of FDA/EMA-approved drugs in patients with GBM

  • 0 views
  • 20 Sep, 2021
  • 1 location
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme

The current design provides a window to analyze the impact of the ACT001+Pembrolizumab combination on the tumor microenvironment and disease outcomes.

  • 0 views
  • 24 Nov, 2021